Work

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

Year: 2011

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2011.06.010

Authors: Sarbjit Saini, Karin E. Rosen, Hsin-Ju Hsieh, Dennis A. Wong, Edward Conner, Allen Kaplan, Sheldon Spector, Marcus Maurer

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Genentech, Medical University of South Carolina, University of California, Los Angeles, Charité – Universitätsmedizin Berlin

Language: English

Topic: Urticaria and Related Conditions

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2085255857

FWCI: 44.88

Cites: 29

Cited by: 396

Related to: 10